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INTRODUCTION
Lung cancer is the most common cause of cancer
deaths in the countries of North America and other
developed countries (1). Despite advances in the de-
tection and treatment of many cancers leading to im-
provements in the 5-year survival rates, the survival
rate for lung cancer continues to be15% (2). The
main reason for the continued low survival rate for
lung cancer patients is that tumors are found at late
invasive stages, when the options for treatment are
mostly palliative. Thus, for the significant reduction of
mortality in lung cancer, the detection and treatment
at earlier stages should be essential. Recent advances
in endoscopic technology such as autofluorescence
bronchoscopy (AFB) have markedly improved the
early detection of premalignant and malignant bron-
chial lesions in high-risk individuals (3, 4). In the pre-
sent report, we describe a case of early-stage lung can-
cer detected by AFB and successfully treated with
photodynamic therapy (PDT).
CASE REPORT
A 71-year-old man was referred to our hospital for
further examination of abnormal sputum cytology
(classⅢ) in May 2003. He was diagnosed as having
chronic pulmonary emphysema in 1982 and secondary
pulmonary hypertension in 2001. Home oxygen ther-
apy had been conducted since 1997. He was a heavy
smoker with a Brinkman Index of 1840 (40 cigarettes/
day for 46 years). Physical examination revealed no
remarkable findings. Peripheral blood count and bio-
chemical examinations were within the normal range.
Among serum tumor markers, carcinoembryonic anti-
gen (CEA) was slightly elevated to 3.6 ng/ml (normal,
2.5 ng/ml) but squamous cell carcinoma related
antigen (SCC), cytokeratin 19 fragment (Cyfra) andpro-
gastrin releasing peptide (proGRP) were within nor-
mal range. Post-inflammatory change in the right apex
pulmonis, hyperinflation and irregular radiolucencies
of the bilateral lung field and dilatation of the pulmo-
nary artery were detected, but no abnormal nodular
shadows were seen in chest X-ray. A chest CT showed
multiple bulla formation and low attenuation area ori-
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ented in centrilobular and panlobular patterns in the
bilateral lungs (Fig. 1). However, no abnormal nodular
opacities and no hilar or mediastinal lymphadenopathy
were observed in chest CT. Pulmonary function tests
showed markedly reduced forced expiratory volume
in one second (FEV1.0 670ml). Arterial blood gas values,
with the patient breathing 2 liters of oxygen perminute
via nasal prongs, were pH 7.415, PaO2 76.2 mmHg,
PaCO2 37.8mmHg and oxygen saturation 95.5%. La-
ryngoscopical examinations revealed no abnormalities.
While some spotty reddened lesionswere found at the
upper division bronchus of the left lung, the precise
location of the tumor was quite difficult to determine
by the inspection with conventional bronchoscopy
alone (Fig. 2A). On the other hand, the location of the
tumor was clearly identified as a defect of autofluo-
rescence by the inspection with AFB (the SAFE-1000
system) at the bifurcation between the left B1+2 and B3
bronchi (Fig. 2 B). No other abnormal lesions were
observed by careful inspectionwith conventional bron-
choscopy and AFB. Transbronchial biopsy obtained
at the bifurcation between the left B1+2 andB3 bronchi
revealed a solid growth pattern of squamous cell car-
cinoma composed of polymorphic tumorous cells with
large and hyperchromatic nuclei and partial keratini-
zation (Fig. 3). No distant metastases were detected
and endobronchial ultrasonography revealed no tumor
invasion beyond the cartilage layer of the bronchial
wall (Fig. 4). Taking all these findings into considera-
tion, the patient was diagnosed as having early-stage
lung cancer. Since he was not eligible for surgical re-
section due to poor pulmonary function and pulmonary
Figure 1. A chest CT film on admission.Multiple bulla formation
and low attenuation area oriented in centrilobular and panlobular
patterns in the bilateral lungs were seen. However, no abnormal
nodular opacities and no hilar or mediastinal lymphadenopathy
were detected.
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Figure 2. (A) Conventional bronchoscopic findings. Whereas
some spotty, reddened lesions were found at the upper division
bronchus of the left lung, the precise location of the tumor was
quite difficult to determine. (B) Autofluorescence bronchoscopic
findings. The location of the tumor was clearly identified as the
defect of autofluorescence (arrow) by AFB (SAFE-1000) at
the bifurcation between the left B1+2and B3 bronchi.
Figure 3. Histological findings of a transbronchial biopsy speci-
men obtained at the bifurcation between the left B1+2 and B3 bronchi
(H.E stain, ×200). A solid growth pattern composed of polymorphic
tumorous cells with large and hyperchromatic nuclei and partial
keratinization was found. Histology was squamous cell carcinoma.
The tumor invaded beyond the basement membrane.
Figure 4. Endobronchial ultrasonography findings. The tumor
(arrow) invasion was shown to be confined within the submuscle
layer and not beyond the cartilage layer (arrow head).
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hypertension, PDT laser irradiation (total 400 kJ) was
performed at 48 hours after Photofrin(2mg/kg) injec-
tion intravenously. Complete response was confirmed
and no severe complications appeared after therapy.
Currently, he is periodically under follow upwith AFB
and no evidence of recurrence has been observed for
nine months.
DISCUSSION
Lung cancer has become the most common cause
of all deaths from cancer and themortality rate of lung
cancer is still increasing. Diagnosis and resection of
lung cancer at an early stage are considered to be ef-
fective based on dramatically improved survival rates
for resected patients with no surgery (5). However,
only minority of patients are diagnosed at these cur-
able stages, because of the limitations in radiographic
technology, the lack of specific symptoms at an early
stage of the disease, and currently available validated
screening test (6).
Advances in endoscopic technology such as AFB
have recently improved the detection of premalignant
and malignant bronchial lesions in high-risk individuals
(7-9). According to previous report, the sensitivity
of biopsy proved squamous dysplasia and carcinoma
in situ detected by white-light bronchoscopy alone
was 61.2%, whereas the sensitivity was significantly
increased to 89.8%with the addition of AFB (9).Among
AFBs, we have been used the SAFE-1000 system
since 2000. The advantages of this system are follow-
ings : 1) it uses simple device such as a standard xenon
lamp with a filter, rather than a laser, 2) it is handier
to carry than the LIFE lung system (10). In the pre-
sent case, the precise location ofmalignant lesion was
clearly detected as a defect of autofluorescence by
the inspection with the SAFE-1000 system, whereas
it was quite difficult by the inspectionwith conventional
bronchoscopy alone. In terms of the diagnosis of early-
stage lung cancer, the visibility of the peripheral edge
of the tumor with bronchoscopy is essential. Because
the range of tumor invasion was accurately identified
by AFB in the present case, the appropriate diagnosis
of early-stage lung cancer was able to be yielded. These
observations strongly imply that the usefulness of
AFB for the detection of early-stage lung cancers.
Carcinogen exposure causes sequentialmorphological
and genetic changes in the bronchial mucosa. Espe-
cially, tobacco, one of the most famous carcinogens,
is well known to lead to multifocal carcinogenesis and
cause synchronous and/or metachronous multiple
lung cancers (11). In the present case, although no
other abnormalities except for the bifurcation between
the left B1+2 and B3 bronchi were observed by careful
inspection with conventional bronchoscopy and AFB,
his heavy smoking habit indicates high risk for occur-
rence ofmetachronousmultiple lung cancers.Because
the repeated inspection with AFB in the high-risk
individuals is reported to be useful for the detection
of premalignant and malignant lesions (11), careful
follow-up with AFB should be required in the present
case.
The increased thickening of the bronchial epithelium
and increases in blood content or vessel growth are
thought to be involved in areas of abnormal autofluo-
rescence irrespective of malignancy or not. As chronic
inflammatory bronchial lesions due tobronchial asthma
and chronic bronchitis are also known to reveal in-
creased thickening of the epithelium and blood con-
tent, the defects of autofluorescence were frequently
observed by the inspectionwith AFB in these lesions.
Therefore, AFB is possible to detect false-positive
lesions in the patients with bronchial asthma and
chronic bronchitis. The relatively low specificity of
AFB to distinguish malignancy or not has been re-
ported as one of the main disadvantages of AFB (3).
For example, the specificity of conventional broncho-
scopy alone was 78%, whereas it was 42% with the ad-
dition of AFB (3). Recently, high magnification bron-
chovideoscope has been developed to overcome this
disadvantage of AFB (12). At sites of abnormal aut-
ofluorescence established by AFB, highmagnification
bronchovideoscopy detects squamousdysplasiamore
accurately than AFB alone (12). Thus, the combined
use of AFBwith highmagnification bronchovideoscopy
may be able to decrease false-positive rate detected
by AFB alone.
Almost all cases of early-stage lung cancer occur
in current heavy smokers or ex-smokers, many of
whom are not eligible for surgical resection due to
synchronous multiple early-stage lung cancers and/
or smoking-related complications, such as poor pul-
monary function and cardio-vascular diseases. Thus,
these cases seem to be good candidates for bronchial
interventions. PDT, brachytherapy, electrocautery,
cryotherapy, and Nd-YAG laser therapy are therapeu-
tic options available formanagement of endobronchial
malignancies. These bronchial interventions have
been reported to be effective for both progressive and
early-stage lung cancers, especially for the latter (13,
14). We treated this case with PDT for the following
reasons : 1) squamous cell carcinoma was histologi-
cally proven, 2) no evidence of lymph node or distant
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metastasis was observed, 3) the peripheral edge of
the tumor was bronchoscopically visible, 4) the tumor
did not exceed the cartilage layer of the bronchial
wall, 5) there was no indication for surgical resection
due to poor pulmonary function and pulmonary hy-
pertension. As described previously (14), PDT was
effective, and a complete response was confirmed
in this case. However, since it is known that early-
stage lung cancers even when successfully treated
with PDT sometimes relapse, careful follow-up will
be required in the present case.
In conclusion, we reported a case of early-stage
lung cancer detected by AFB and successfully treated
with PDT. AFB is a very promising tool for the early
detection of premalignant and malignant bronchial
lesions in high-risk individuals. The early detection
of lung cancer by AFB combinedwith early treatment
including bronchial interventional procedures might
lead to a significant reduction of mortality in lung
cancer.
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